• レポートコード:MRC2-11QY11717 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、95ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は創薬のグローバル市場について調査・分析したレポートです。種類別(小分子薬、生物製剤)市場規模、用途別(研究所、製薬会社、バイオテクノロジー会社)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別創薬の競争状況、市場シェア ・世界の創薬市場:種類別市場規模 2015年-2020年(小分子薬、生物製剤) ・世界の創薬市場:種類別市場規模予測 2021年-2026年(小分子薬、生物製剤) ・世界の創薬市場:用途別市場規模 2015年-2020年(研究所、製薬会社、バイオテクノロジー会社) ・世界の創薬市場:用途別市場規模予測 2021年-2026年(研究所、製薬会社、バイオテクノロジー会社) ・北米の創薬市場分析:米国、カナダ ・ヨーロッパの創薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの創薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の創薬市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの創薬市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Pfizer、GSK、Merck、Agilent、Eli Lilly and Company、Roche、Bayer、Abbott、AstraZeneca、Shimadzu ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug discovery is the process by which new candidate medications are discovered.
The pharmaceutical and biotech companies are increasing their collaboration with contract development and manufacturing organizations, thus playing a crucial role in the development and innovation of new drugs. Other factors contributing to the growth of this market are – rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.
Market Analysis and Insights: Global Drug Discovery Market
The global Drug Discovery market size is projected to reach US$ 40930 million by 2026, from US$ 37940 million in 2020, at a CAGR of 7.3%% during 2021-2026.
Global Drug Discovery Scope and Market Size
Drug Discovery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Market segment by Type, the product can be split into
Small Molecule Drug
Biologics Drug
Market segment by Application, split into
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Discovery Revenue
1.4 Market by Type
1.4.1 Global Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Small Molecule Drug
1.4.3 Biologics Drug
1.5 Market by Application
1.5.1 Global Drug Discovery Market Share by Application: 2020 VS 2026
1.5.2 Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Market Perspective (2015-2026)
2.2 Global Drug Discovery Growth Trends by Regions
2.2.1 Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug Discovery Historic Market Share by Regions (2015-2020)
2.2.3 Drug Discovery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Drug Discovery Market Growth Strategy
2.3.6 Primary Interviews with Key Drug Discovery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Players by Market Size
3.1.1 Global Top Drug Discovery Players by Revenue (2015-2020)
3.1.2 Global Drug Discovery Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Discovery Market Concentration Ratio
3.2.1 Global Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug Discovery Revenue in 2019
3.3 Drug Discovery Key Players Head office and Area Served
3.4 Key Players Drug Discovery Product Solution and Service
3.5 Date of Enter into Drug Discovery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drug Discovery Historic Market Size by Type (2015-2020)
4.2 Global Drug Discovery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Drug Discovery Market Size by Application (2015-2020)
5.2 Global Drug Discovery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug Discovery Market Size (2015-2020)
6.2 Drug Discovery Key Players in North America (2019-2020)
6.3 North America Drug Discovery Market Size by Type (2015-2020)
6.4 North America Drug Discovery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Drug Discovery Market Size (2015-2020)
7.2 Drug Discovery Key Players in Europe (2019-2020)
7.3 Europe Drug Discovery Market Size by Type (2015-2020)
7.4 Europe Drug Discovery Market Size by Application (2015-2020)
8 China
8.1 China Drug Discovery Market Size (2015-2020)
8.2 Drug Discovery Key Players in China (2019-2020)
8.3 China Drug Discovery Market Size by Type (2015-2020)
8.4 China Drug Discovery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Drug Discovery Market Size (2015-2020)
9.2 Drug Discovery Key Players in Japan (2019-2020)
9.3 Japan Drug Discovery Market Size by Type (2015-2020)
9.4 Japan Drug Discovery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Drug Discovery Market Size (2015-2020)
10.2 Drug Discovery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Discovery Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Discovery Market Size by Application (2015-2020)
11 India
11.1 India Drug Discovery Market Size (2015-2020)
11.2 Drug Discovery Key Players in India (2019-2020)
11.3 India Drug Discovery Market Size by Type (2015-2020)
11.4 India Drug Discovery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Drug Discovery Market Size (2015-2020)
12.2 Drug Discovery Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Discovery Market Size by Type (2015-2020)
12.4 Central & South America Drug Discovery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Drug Discovery Introduction
13.1.4 Pfizer Revenue in Drug Discovery Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Drug Discovery Introduction
13.2.4 GSK Revenue in Drug Discovery Business (2015-2020)
13.2.5 GSK Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Drug Discovery Introduction
13.3.4 Merck Revenue in Drug Discovery Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Agilent
13.4.1 Agilent Company Details
13.4.2 Agilent Business Overview
13.4.3 Agilent Drug Discovery Introduction
13.4.4 Agilent Revenue in Drug Discovery Business (2015-2020)
13.4.5 Agilent Recent Development
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Details
13.5.2 Eli Lilly and Company Business Overview
13.5.3 Eli Lilly and Company Drug Discovery Introduction
13.5.4 Eli Lilly and Company Revenue in Drug Discovery Business (2015-2020)
13.5.5 Eli Lilly and Company Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Drug Discovery Introduction
13.6.4 Roche Revenue in Drug Discovery Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Bayer
13.7.1 Bayer Company Details
13.7.2 Bayer Business Overview
13.7.3 Bayer Drug Discovery Introduction
13.7.4 Bayer Revenue in Drug Discovery Business (2015-2020)
13.7.5 Bayer Recent Development
13.8 Abbott
13.8.1 Abbott Company Details
13.8.2 Abbott Business Overview
13.8.3 Abbott Drug Discovery Introduction
13.8.4 Abbott Revenue in Drug Discovery Business (2015-2020)
13.8.5 Abbott Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview
13.9.3 AstraZeneca Drug Discovery Introduction
13.9.4 AstraZeneca Revenue in Drug Discovery Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Shimadzu
13.10.1 Shimadzu Company Details
13.10.2 Shimadzu Business Overview
13.10.3 Shimadzu Drug Discovery Introduction
13.10.4 Shimadzu Revenue in Drug Discovery Business (2015-2020)
13.10.5 Shimadzu Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Drug Discovery Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Discovery Revenue
Table 3. Ranking of Global Top Drug Discovery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Small Molecule Drug
Table 6. Key Players of Biologics Drug
Table 7. Global Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Drug Discovery Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Drug Discovery Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Drug Discovery Market Share by Regions (2015-2020)
Table 11. Global Drug Discovery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Drug Discovery Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Drug Discovery Market Growth Strategy
Table 17. Main Points Interviewed from Key Drug Discovery Players
Table 18. Global Drug Discovery Revenue by Players (2015-2020) (Million US$)
Table 19. Global Drug Discovery Market Share by Players (2015-2020)
Table 20. Global Top Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Discovery as of 2019)
Table 21. Global Drug Discovery by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Discovery Product Solution and Service
Table 24. Date of Enter into Drug Discovery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 27. Global Drug Discovery Market Size Share by Type (2015-2020)
Table 28. Global Drug Discovery Revenue Market Share by Type (2021-2026)
Table 29. Global Drug Discovery Market Size Share by Application (2015-2020)
Table 30. Global Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 31. Global Drug Discovery Market Size Share by Application (2021-2026)
Table 32. North America Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Drug Discovery Market Share (2019-2020)
Table 34. North America Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 35. North America Drug Discovery Market Share by Type (2015-2020)
Table 36. North America Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 37. North America Drug Discovery Market Share by Application (2015-2020)
Table 38. Europe Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Drug Discovery Market Share (2019-2020)
Table 40. Europe Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Drug Discovery Market Share by Type (2015-2020)
Table 42. Europe Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Drug Discovery Market Share by Application (2015-2020)
Table 44. China Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 45. China Key Players Drug Discovery Market Share (2019-2020)
Table 46. China Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 47. China Drug Discovery Market Share by Type (2015-2020)
Table 48. China Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 49. China Drug Discovery Market Share by Application (2015-2020)
Table 50. Japan Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Drug Discovery Market Share (2019-2020)
Table 52. Japan Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Drug Discovery Market Share by Type (2015-2020)
Table 54. Japan Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Drug Discovery Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Drug Discovery Market Share (2019-2020)
Table 58. Southeast Asia Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Drug Discovery Market Share by Type (2015-2020)
Table 60. Southeast Asia Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Drug Discovery Market Share by Application (2015-2020)
Table 62. India Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 63. India Key Players Drug Discovery Market Share (2019-2020)
Table 64. India Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 65. India Drug Discovery Market Share by Type (2015-2020)
Table 66. India Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 67. India Drug Discovery Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Drug Discovery Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Drug Discovery Market Share (2019-2020)
Table 70. Central & South America Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Drug Discovery Market Share by Type (2015-2020)
Table 72. Central & South America Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Drug Discovery Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Agilent Company Details
Table 90. Agilent Business Overview
Table 91. Agilent Product
Table 92. Agilent Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 93. Agilent Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Product
Table 97. Eli Lilly and Company Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 98. Eli Lilly and Company Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Product
Table 107. Bayer Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 108. Bayer Recent Development
Table 109. Abbott Business Overview
Table 110. Abbott Product
Table 111. Abbott Company Details
Table 112. Abbott Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 113. Abbott Recent Development
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Product
Table 117. AstraZeneca Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 118. AstraZeneca Recent Development
Table 119. Shimadzu Company Details
Table 120. Shimadzu Business Overview
Table 121. Shimadzu Product
Table 122. Shimadzu Revenue in Drug Discovery Business (2015-2020) (Million US$)
Table 123. Shimadzu Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Discovery Market Share by Type: 2020 VS 2026
Figure 2. Small Molecule Drug Features
Figure 3. Biologics Drug Features
Figure 4. Global Drug Discovery Market Share by Application: 2020 VS 2026
Figure 5. Research Institutes Case Studies
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Biotechnology Companies Case Studies
Figure 8. Drug Discovery Report Years Considered
Figure 9. Global Drug Discovery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Drug Discovery Market Share by Regions: 2020 VS 2026
Figure 11. Global Drug Discovery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Drug Discovery Market Share by Players in 2019
Figure 14. Global Top Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Discovery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Drug Discovery Revenue in 2019
Figure 16. North America Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed